Francesco Berlanda Scorza
Francesco Berlanda Scorza
PATH
Verified email at path.org - Homepage
TitleCited byYear
Proteomics characterization of outer membrane vesicles from the extraintestinal pathogenic Escherichia coli ΔtolR IHE3034 mutant
FB Scorza, F Doro, MJ Rodríguez-Ortega, M Stella, S Liberatori, ...
Molecular & Cellular Proteomics 7 (3), 473-485, 2008
1302008
The Caenorhabditis elegans elongator complex regulates neuronal α-tubulin acetylation
JA Solinger, R Paolinelli, H Klöß, FB Scorza, S Marchesi, U Sauder, ...
PLoS genetics 6 (1), e1000820, 2010
962010
A novel phase variation mechanism in the meningococcus driven by a ligand-responsive repressor and differential spacing of distal promoter elements
MME Metruccio, E Pigozzi, D Roncarati, FB Scorza, N Norais, SA Hill, ...
PLoS pathogens 5 (12), e1000710, 2009
862009
Universal influenza vaccines: Shifting to better vaccines
FB Scorza, V Tsvetnitsky, JJ Donnelly
Vaccine 34 (26), 2926-2933, 2016
822016
Breathing life into pathogens: the influence of oxygen on bacterial virulence and host responses in the gastrointestinal tract
B Marteyn, FB Scorza, PJ Sansonetti, C Tang
Cellular microbiology 13 (2), 171-176, 2011
772011
High yield production process for Shigella outer membrane particles
FB Scorza, AM Colucci, L Maggiore, S Sanzone, O Rossi, I Ferlenghi, ...
PloS one 7 (6), e35616, 2012
652012
Proteins and nucleic acids from meningitis/sepsis-associated Escherichia coli
V Masignani, DG Moriel, FB Scorza, N Norais, MR Fontana, M Pizza, ...
US Patent 8,758,764, 2014
642014
Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro
E Bartolini, E Ianni, E Frigimelica, R Petracca, G Galli, F Berlanda Scorza, ...
Journal of extracellular vesicles 2 (1), 20181, 2013
442013
Self-amplifying mRNA vaccines
GAJ Brito LA, Kommareddy S, Maione D, Uematsu Y, Giovani C, Berlanda Scorza ...
Nonviral Vectors for Gene Therapy Physical Methods and Medical Translation …, 2015
41*2015
New kids on the block: RNA-based influenza virus vaccines
F Scorza, N Pardi
Vaccines 6 (2), 20, 2018
142018
Randomized safety and immunogenicity trial of a seasonal trivalent inactivated split virion influenza vaccine (IVACFLU-S) in healthy young Vietnamese adults
DD Anh, VD Thiem, NTH Anh, VM Huong, NT Nga, TC Thang, DH Thai, ...
Vaccine 34 (45), 5457-5462, 2016
92016
Rna purification methods
FB Scorza, Y Wen, A Geall, F Porter
US Patent App. 14/775,760, 2016
92016
Proteins and nucleic acids from meningitis/sepsis-associated Escherichia coli
V Masignani, DG Moriel, FB Scorza, N Norais, MR Fontana, M Pizza, ...
US Patent 9,334,313, 2016
82016
Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli
V Masignani, DG Moriel, FB Scorza, N Norais, MR Fontana, M Pizza, ...
US Patent App. 15/150,204, 2016
52016
Advancing new vaccines against pandemic influenza in low-resource countries
FB Scorza
Vaccine 35 (40), 5397-5402, 2017
42017
Chemistry, manufacturing and control (CMC) and clinical trial technical support for influenza vaccine manufacturers
R Wahid, R Holt, R Hjorth, FB Scorza
Vaccine 34 (45), 5430-5435, 2016
42016
Immunogens from uropathogenic escherichia coli
FB Scorza, DG Moriel, J Hacker, M Pizza, L Serino, MR Fontana
US Patent App. 12/377,572, 2010
4*2010
Safety and immunogenicity of a seasonal trivalent inactivated split influenza vaccine: a phase I randomized clinical trial in healthy Serbian adults
G Stevanovic, L Lavadinovic, S Filipovic Vignjevic, R Holt, K Ilic, ...
Human vaccines & immunotherapeutics 14 (3), 579-586, 2018
22018
Hyperblebbing Shigella Strains
C Gerke, FB Scorza, A Saul, L Maggiore
US Patent App. 15/094,077, 2016
22016
Hyperblebbing shigella strains
C Gerke, FB Scorza, A Saul, L Maggiore
US Patent App. 13/498,723, 2013
22013
The system can't perform the operation now. Try again later.
Articles 1–20